transgen
plant
altern
costli
system
recombin
immunogen
protein
expr
sion
sourc
product
cheap
highli
effici
biotherapeut
new
gener
includ
plant
vaccin
present
review
possibl
plant
system
applic
product
recombin
protein
veterinari
use
consid
histori
edibl
vaccin
concept
briefli
summar
advantag
disadvantag
variou
plant
system
express
recombin
immu
nogen
protein
discuss
list
recombin
plant
vaccin
veterinari
use
differ
ent
stage
clinic
trial
present
abbrevi
tmvtobacco
mosaic
viru
tsptotal
solubl
protein
mani
thousand
year
plant
serv
human
sourc
medicin
substanc
ever
turn
centuri
xxi
appear
dna
technolog
becam
possibl
modifi
plant
genom
creat
new
type
plant
transgen
plant
capabl
syn
thesiz
accumul
tissu
recombi
nant
protein
variou
heterolog
system
date
transgen
plant
nuclear
chloro
plast
genom
transform
gene
encod
heterolog
protein
import
treatment
variou
diseas
antigen
infec
tiou
agent
antibodi
immunomodul
etc
creat
princip
import
work
develop
creation
edibl
vaccin
concept
essenc
use
genet
modifi
plant
contain
protein
anti
gen
infecti
agent
oral
deliveri
relev
antigen
mucosa
gastrointestin
tract
warm
blood
anim
vaccin
base
program
spe
cific
mechan
warm
blood
anim
protect
pathogen
effici
method
struggl
infecti
diseas
often
result
mass
mortal
agricultur
alterna
tive
livestock
vaccin
anti
viral
drug
suitabl
wide
use
anim
husbandri
import
anim
vaccin
indirectli
affect
human
health
use
vaccin
significantli
reduc
amount
pharma
ceutic
food
chain
rule
anim
immun
mechan
acti
vate
direct
introduct
infecti
agent
compon
present
use
vaccin
prepar
basi
inactiv
agent
although
vaccin
manifest
high
immunog
niciti
without
seriou
shortcom
among
disadvantag
increas
sensitiv
iti
organ
larg
load
immun
system
reactogen
vaccin
side
effect
toxic
etc
applic
molecular
biolog
genet
engin
method
open
wide
prospect
manufactur
vaccin
new
gener
immunogen
compon
biolog
mole
cule
fragment
dna
fragment
protein
infecti
agent
cell
envelop
serv
immu
nogen
compon
gene
encod
envelop
protein
infecti
agent
transfer
genom
anoth
organ
exampl
plant
cell
plant
synthes
protein
antigen
capabl
format
resist
agent
thu
introduct
organ
whole
pathogen
part
capabl
induc
infect
develop
pro
vide
effect
vaccin
one
fourth
total
pharmaceut
market
drug
veterinari
use
constantli
expand
prepar
medicin
substanc
pro
duction
veterinari
product
base
variou
approach
includ
biotechnolog
use
genet
modifi
transgen
organ
purpos
express
system
bacteria
yeast
cell
insect
mammal
use
applic
genet
modifi
plant
gene
encod
phar
maceut
protein
insert
genom
open
new
prospect
obtain
recombin
protein
includ
ing
plant
vaccin
review
devot
analysi
possibl
produc
recombin
immunogen
protein
veterinari
use
basi
plant
express
system
histori
concept
edibl
vaccin
anim
immun
plant
vaccin
idea
usag
plant
cell
synthesi
accumul
recombin
protein
antigen
first
time
success
realiz
c
arntzen
colleagu
team
research
demonstr
possibl
accumul
surfac
hbsag
antigen
hepati
ti
b
viru
also
capabl
self
assembl
viru
like
particl
transgen
tobacco
plant
viru
like
particl
isol
plant
tissu
ident
particl
hbsag
antigen
indu
trial
recombin
vaccin
obtain
yeast
expr
sion
system
also
viru
like
particl
blood
plasma
patient
infect
hepat
b
viru
thu
becam
obviou
genet
modi
fie
plant
produc
accumul
protein
anti
gen
variou
infecti
agent
use
oral
deliveri
correspond
agent
mucosa
gastrointestin
tract
warm
blood
anim
ie
edibl
vaccin
next
import
step
develop
edibl
vaccin
concept
basi
genet
modifi
plant
creation
transgen
plant
produc
heat
labil
enterotoxin
escherichia
coli
b
subunit
cholera
toxin
heat
labil
toxin
e
coli
consist
two
part
lt
enzym
lt
b
pentam
receptor
bind
polypeptid
lt
b
bind
receptor
sur
face
membran
epitheli
cell
mammal
small
intestin
transport
lt
intestin
cell
induc
chang
cell
metabol
cell
dehydr
two
part
heat
labil
enterotoxin
separ
appear
lt
b
protein
complex
surfac
epitheliocyt
stimul
strong
immun
respons
intestin
mucosa
without
appear
diseas
sign
featur
basi
research
c
arntzen
team
creation
plant
vaccin
provid
resist
enterotoxigen
e
coli
toxin
author
establish
lt
b
synthes
transgen
tobacco
potato
plant
also
lt
b
isol
e
coli
deliv
oral
mice
induc
similar
immun
respons
later
lt
b
sequenc
optim
express
plant
cell
transfer
potato
genom
potato
tuber
protein
assembl
correctli
oligom
accumul
amount
suffi
cient
induct
immun
respons
oral
deliveri
organ
basi
clinic
trial
candid
plant
lt
b
vaccin
estab
lish
consumpt
raw
potato
tuber
con
tain
mg
lt
b
volunt
result
format
serum
mucos
immun
respons
high
titer
antibodi
initi
concept
edibl
vaccin
heavili
critic
research
believ
aggress
medium
gastrointestin
tract
recombin
protein
destroy
howev
later
experiment
establish
recom
binant
b
subunit
cholera
toxin
fuse
green
fluoresc
protein
gfp
protect
plant
cellu
lose
cell
wall
oral
deliveri
capabl
pass
gastrointestin
tract
reach
antigen
contain
cell
mous
intestin
result
obtain
confirm
possibl
use
plant
synthes
protein
antigen
variou
infec
tiou
agent
oral
deliveri
antigen
mucosa
gastrointestin
tract
experiment
con
firm
consist
edibl
vaccin
concept
becam
evid
genet
modifi
plant
use
creation
plant
vaccin
raw
mate
rial
separ
plant
part
fruit
root
berri
leav
etc
use
directli
food
without
pre
liminari
heat
treatment
respons
format
process
evolut
mammal
develop
secondari
lymphoid
mucos
tissu
capabl
antigen
absorpt
process
use
induc
tion
mucos
respons
establish
case
cellular
humor
immun
form
import
adapt
mucos
immun
distinguish
usual
food
symbiot
antigen
infecti
agent
scheme
mechan
mucos
immun
respons
format
present
fig
digest
tract
one
pathway
penetr
varieti
pathogen
organ
main
associ
lymphoid
tissu
peyer
patch
peyer
patch
induct
site
intestin
contain
dome
underli
fol
licl
b
zone
germin
center
interfollicu
lar
region
contain
cell
surfac
dome
cover
special
follicl
associ
epith
lium
contain
fold
cell
cell
abl
absorb
transport
antigen
intesti
nal
lumen
success
captur
antigen
par
tialli
cleav
enter
dendrit
cell
see
fig
step
dendrit
cell
especi
import
initi
adapt
immun
respons
sinc
migrat
lymph
node
see
fig
step
mediat
act
develop
variou
subpopu
lation
helper
cell
naiv
lymphocyt
also
interact
b
lymphocyt
see
fig
step
activ
b
cell
leav
peyer
patch
penetr
circulatori
system
matur
helper
cell
return
mucosa
sur
pathogen
antigen
epithelium
helper
cell
face
function
effector
see
fig
step
helper
express
interleukin
il
increas
express
receptor
polymer
immunoglobulin
pig
secret
antigen
spe
cific
iga
fig
step
subsequ
gener
matur
plasma
cell
produc
iga
lead
induct
antigen
specif
protect
local
distal
mucos
surfac
sinc
mucos
immun
respons
gener
ize
natur
oral
ie
mucos
vaccin
immun
respons
mucou
membran
also
overal
immun
respons
organ
prove
vaccin
via
surfac
mucosa
membran
specif
activ
immun
respons
infect
without
develop
ment
process
relat
diseas
inflamm
toxic
plant
vaccin
comparison
tradit
express
system
plant
system
attract
research
mani
way
primarili
due
absenc
risk
plant
cell
infect
anim
pathogen
virus
prion
etc
plant
capabl
synthesi
recom
binant
antigen
posttransl
modi
ficat
anim
cell
plant
vaccin
play
especi
import
role
protect
ani
mal
diarrheal
diseas
diseas
infecti
agent
penetr
organ
mucos
tissu
modern
techniqu
genet
engin
allow
select
direct
recombin
protein
express
plant
cell
variou
plant
organ
seed
tuber
fruit
etc
possibl
greatli
simplifi
larg
scale
product
plant
vaccin
reduc
cost
accord
expert
final
price
product
recombin
protein
produc
plant
express
system
much
less
price
similar
protein
produc
exampl
mammalian
cell
cultur
sinc
recombin
protein
accumul
storag
organ
seed
abl
main
tain
without
chang
loss
biolog
activ
long
time
month
year
establish
recombin
protein
cholera
toxin
b
subunit
remain
stabl
transgen
rice
grain
least
month
grain
store
room
temperatur
condit
recombi
nant
protein
antigen
remain
stabl
rice
grain
three
year
provid
format
protect
immun
mice
cholera
agent
enterotoxigen
e
coli
soybean
seed
soy
milk
preserv
antigen
stabil
iti
observ
four
year
thu
grain
transgen
plant
transport
site
final
destin
without
addit
freez
treatment
ensur
retent
activ
recom
binant
protein
activ
stabil
constanc
dosag
somewhat
differ
pictur
observ
lyo
philiz
use
method
conserv
protein
antigen
synthes
plant
cell
establish
recombin
protein
noroviru
envelop
retain
immunogen
ti
sue
lyophil
air
dri
tomato
fruit
test
sampl
differ
immunogen
iti
immunogen
recombin
protein
air
dri
tomato
fruit
somewhat
higher
comparison
lyophil
fruit
similar
result
obtain
experi
lyophil
potato
tuber
synthes
protein
noroviru
envelop
eg
immunogen
lyophil
tuber
lower
fresh
tuber
ever
addit
studi
requir
final
solu
tion
question
despit
advantag
plant
vaccin
without
disadvantag
one
differ
protein
posttransl
modif
plant
anim
eg
glycosyl
recombin
pro
tein
known
half
protein
synthes
eukaryot
cell
glycosyl
third
current
appli
biopharmaceu
tic
glycoprotein
although
activ
protein
depend
glycosyl
case
may
critic
specif
featur
pro
tein
glycoform
affect
fold
stabil
tran
portat
chang
function
activ
immunogen
exampl
biopharmaceut
function
activ
depend
specif
gli
coform
erythropoietin
antibodi
blood
anti
gen
interferon
hormon
scheme
n
glycan
complex
format
plant
anim
human
exampl
shown
fig
signific
differ
glycosyl
plant
xylos
attach
core
mannos
residu
fucos
n
acetylglu
cosamin
residu
core
glycan
human
cell
xylos
use
glycosyl
proxim
fucos
residu
attach
glycan
bond
establish
sugar
residu
attach
posttransl
modif
recom
binant
protein
plant
cell
capabl
exhibit
immunogen
approxim
one
quarter
patient
allergi
symptom
ige
antibodi
specif
complex
glycan
includ
xylos
fucos
reveal
differ
enc
glycosyl
posttransl
modi
ficat
recombin
protein
plant
mam
mal
cell
elimin
genet
engin
techniqu
success
demonstr
moss
physcomitrella
paten
gene
encod
enzym
xylosyltransferas
fucosyltransferas
respons
respect
xylosyl
fucosyl
protein
switch
knock
method
known
foreign
gene
insert
genom
transgen
plant
level
express
depend
site
insert
determin
level
protein
antigen
particular
accumul
plant
tissu
connect
one
disadvantag
plant
vaccin
difficulti
standard
dosag
stage
develop
edibl
vaccin
concept
undergon
substanti
revis
sinc
possibl
oral
deliveri
recombin
antigen
raw
plant
materi
unten
variabl
recombin
protein
content
accord
research
involv
develop
candi
date
plant
vaccin
antigen
dosag
problem
plant
tissu
success
solv
intro
duction
addit
treatment
plant
materi
refin
equal
concentr
antigen
dri
lyophil
also
necessari
introduc
addit
stage
associ
develop
rapid
method
determin
monitor
dosag
recombin
antigen
appropri
prepar
plant
vaccin
encapsul
tablet
use
practic
correspond
medic
supervis
thu
perform
studi
allow
suggest
plant
vaccin
base
genet
modifi
plant
capabl
induc
protect
immun
open
new
opportun
creation
low
cost
easi
handl
vaccin
infecti
diseas
anim
import
develop
date
highli
effect
method
cultiv
agro
eco
nomic
import
plant
speci
well
seed
product
system
particular
cultur
make
plant
attract
use
biofactori
man
ufactur
cheap
recombin
protein
medic
purpos
roplast
among
plant
express
system
stabl
integr
transgen
nuclear
genom
separ
group
includ
cultiv
duckwe
microalga
cell
cultur
system
vitro
cell
su
pension
cultur
hairi
root
moss
protonema
cultiv
condit
complet
close
environ
bioreactor
promis
transient
express
system
target
gene
intro
duce
plant
cell
express
short
period
time
sever
day
integr
genom
express
system
advantag
disadvantag
main
detail
system
consid
wide
use
system
heterolog
gene
express
particular
plant
vaccin
product
transgen
plant
stabl
integr
transgen
nuclear
genom
creation
plant
involv
transfer
foreign
gene
genom
plant
cell
use
agrobacterium
tumefa
cien
bioballist
subsequ
regener
transform
plant
cell
insert
nuclear
genom
transgen
becom
resi
dent
part
stabli
express
maintain
subsequ
gener
use
express
system
produc
recom
binant
protein
includ
plant
vaccin
still
ham
pere
rel
low
level
transgen
express
rule
less
total
solubl
protein
tsp
also
variabl
differ
plant
organ
tissu
within
singl
plant
differ
plant
often
variabl
express
transgen
due
random
natur
insert
nuclear
genom
effect
posit
may
associ
ate
partial
complet
transgen
inactiv
expert
believ
use
plant
express
sy
tem
obtain
plant
vaccin
econom
bene
ficial
level
express
target
gene
allow
accumul
recombin
protein
amount
less
tsp
lot
way
increas
level
foreign
gene
express
transgen
plant
develop
fulli
discuss
review
among
optim
codon
composit
target
sequenc
usag
strong
promot
addit
intron
region
bind
nuclear
matrix
sar
other
search
ti
sue
organ
specif
promot
ie
promot
provid
target
gene
express
definit
plant
tissu
organ
special
interest
exampl
usag
promot
direct
transcript
target
gene
predominantli
seed
increas
yield
target
protein
order
sever
fold
tsp
rice
grain
tsp
tobacco
seed
import
compar
leav
seed
contain
less
pro
teas
much
less
water
therefor
recombin
protein
save
better
despit
fact
transgen
plant
stabl
transgen
express
nuclear
genom
use
wide
express
system
induc
cautiou
attitud
human
societi
one
fear
associ
possibl
transgen
transfer
cross
pollin
plant
genom
wild
rel
grow
biotechnolog
crop
open
field
solv
problem
research
develop
variou
agricultur
technolog
well
fix
male
steril
transgen
plant
prevent
unwant
cross
pollin
cultiv
wild
spe
cie
exampl
product
variou
immunogen
protein
use
purpos
transgen
plant
stabl
transgen
integr
nuclear
genom
present
tabl
chloroplast
attract
among
plant
express
system
genet
modifi
plant
stabl
transgen
integr
chloroplast
genom
call
transplastom
plant
specif
organ
chloroplast
allow
achiev
high
dose
foreign
gene
transplastom
plant
provid
effici
product
target
pro
tein
record
recombin
protein
yield
achiev
transplastom
tobacco
plant
bacteriophag
lysin
gene
plygb
encod
hydro
lase
bacteri
cell
wall
level
accu
mulat
leav
amount
tsp
although
case
neg
physiolog
chang
observ
plant
high
level
foreign
gene
express
usual
devia
tion
develop
plant
problem
transplastom
plant
adapt
high
level
eign
gene
express
discuss
review
balli
et
al
transgen
deliveri
chloroplast
perform
use
bioballist
gene
gun
integr
chloroplast
genom
occur
via
homolog
recombi
nation
advantag
chloroplast
express
system
absenc
effect
posit
observ
case
random
pattern
transgen
distribut
nuclear
genom
plastid
transgen
splice
inactiv
therefor
express
stabli
preserv
subsequ
genera
tion
due
prokaryot
organ
chloro
plast
genom
possibl
co
express
sever
gene
within
singl
operon
impor
tant
specif
plastid
inherit
matern
line
usual
absent
pollen
therefor
distinct
usual
transgen
plant
transplastom
plant
safe
environ
uncontrol
spread
transgen
plant
prevent
note
protein
posttransl
modif
eg
assembl
multim
protein
tmvtobacco
mosaic
viru
camvcauliflow
mosaic
viru
tsptotal
solubl
protein
immun
respons
reveal
oral
immun
immun
respons
reveal
oral
immun
anim
die
viru
infect
speci
immun
anim
indic
way
antigen
deliveri
indic
case
oral
amount
surviv
infect
anim
indic
case
surviv
less
format
disulfid
bridg
lipid
modif
etc
occur
success
chloroplast
estab
lish
recombin
protein
synthes
chlo
roplast
differ
nativ
one
func
tional
activ
chloroplast
attract
system
recombin
protein
express
fact
close
structur
preserv
metabolit
releas
cytosol
toxic
plant
cell
b
subunit
cholera
toxin
trihalos
tobacco
cell
basi
work
becom
appar
ent
transplastom
plant
regard
promis
system
effici
product
pro
tein
antigen
howev
main
disadvantag
express
system
plant
vaccin
manufactur
chloroplast
glycosyl
protein
present
creation
transplastom
plant
also
associ
technolog
problem
relat
absenc
effici
system
regener
plant
speci
also
absenc
effici
system
transgen
deliveri
chloroplast
genom
provid
high
percent
transform
plant
yield
suspens
cell
cultur
basi
geneti
calli
modifi
plant
attract
attent
research
er
promis
potenti
system
biopharmaceu
tic
product
cultur
obtain
loos
callu
tissu
induc
genet
modifi
explant
basi
co
cultur
cell
su
pension
tumefascien
assess
growth
characterist
cell
line
screen
obtain
promis
line
capabl
accumul
great
amount
recombin
protein
line
cultiv
bioreactor
target
protein
obtain
attract
featur
cell
cultur
expr
sion
system
recombin
protein
product
compar
use
whole
plant
purpos
cell
cultur
unifi
growth
charact
istic
cell
dimens
type
moreov
cell
grown
strictli
control
condit
product
accumul
depend
sea
sonal
weather
chang
allow
perman
product
obtain
bioreactor
addit
insert
signal
peptid
nucleotid
sequenc
construct
permit
protein
secret
intercellular
space
allow
target
protein
isola
tion
directli
cultur
liquid
addit
recombin
protein
stabil
suspens
cul
ture
increas
yield
target
protein
capabl
plant
cell
cultur
compa
rabl
product
therapeut
recombin
pro
tein
convent
use
mammalian
cell
cultur
chines
hamster
ovari
cell
ever
distinct
mammal
suspens
cultur
infect
anim
pathogen
data
mani
exampl
plant
cell
cultur
yield
recombin
protein
amount
mgl
threshold
valu
start
commerci
manufactur
product
exampl
commerci
success
produc
tion
veterinari
vaccin
product
develop
dow
agro
scienc
compani
unit
state
system
patent
effect
safe
system
product
vaccin
protein
cultur
plant
cell
cultur
bioreactor
first
plant
vaccin
newcastl
diseas
viru
bird
obtain
tobacco
cell
cultur
approv
use
min
istri
agricultur
unit
state
disadvantag
express
system
still
insuffici
high
yield
target
recombin
pro
tein
instabl
foreign
gene
cultur
plant
cell
due
epigenet
silenc
tran
gene
transcript
advantag
disadvantag
specif
featur
recombin
protein
produc
tion
plant
cell
cultur
discuss
review
mani
exampl
success
use
aqueou
plant
duckwe
unicellular
alga
moss
cultiv
similarli
plant
cell
suspens
bioreactor
recombin
pro
tein
express
duckwe
attract
attent
research
potenti
highli
effici
system
recombin
pro
tein
express
due
capabl
rapid
biomass
accumul
doubl
h
geneti
calli
modifi
duckwe
potenti
produc
biopharmaceut
protein
use
anim
raw
dri
food
duckwe
monocotyledon
angiosperm
foreign
gene
transfer
genom
method
agrobacteri
transform
bioballist
use
exampl
known
genet
modifi
duckwe
accumul
recombi
nant
protein
amount
tsp
assess
accumul
gfp
sequenc
ing
duckwe
chloroplast
genom
close
com
plete
open
prospect
signifi
cant
increas
yield
recombin
protein
system
biopharmaceut
product
use
genet
modifi
microalga
activ
develop
alga
combin
advantag
bacteria
rapid
growth
simplic
cultiv
higher
plant
capabl
posttransl
modif
photosynthesi
chlamydomona
reinhardtii
promis
among
alga
short
time
bio
mass
doubl
h
easili
subject
nuclear
chloroplast
transform
grown
photoautotroph
condit
addit
acet
sourc
carbon
nuclear
transform
usual
give
rather
low
yield
protein
product
therefor
recombin
protein
product
alga
base
transform
chloro
plast
occupi
cell
volum
c
reinhardtii
nuclear
chloroplast
genom
sequenc
simplifi
substanti
genet
engin
manipul
known
exampl
protein
antigen
product
chloroplast
c
reinhardtii
b
subunit
cholera
toxin
fuse
coat
protein
foot
mouth
diseas
viru
fibronectin
bind
domain
staphylococ
cu
aureu
well
protein
viru
cryptokari
osi
shrimp
diseas
protein
swine
fever
green
moss
physcomitrella
paten
repres
bryophyt
genom
current
complet
sequenc
approach
transform
develop
peculiar
moss
stage
haploid
juvenil
game
tophyt
protonema
moss
morpholog
similar
filament
alga
easili
enough
culti
vate
bioreactor
certain
cultur
condit
moss
stage
protonema
indefinit
long
attract
moss
spe
cie
system
recombin
protein
express
distinct
plant
fragment
foreign
dna
integr
genom
homo
logic
recombin
reduc
substanti
possibl
transfer
gene
inactiv
p
pat
en
cell
capabl
postransl
modif
protein
eukaryot
origin
sinc
step
gametophyt
moss
haploid
number
chromosom
becom
possibl
modifi
func
tion
individu
gene
particular
moss
line
conduct
glycosyl
recombin
protein
mammalian
cell
type
obtain
firm
grenov
germani
develop
technolog
biopharmaceut
protein
product
basi
p
paten
bioreactor
express
system
pro
duce
biopharmaceut
base
green
moss
part
food
chain
character
high
degre
biosafeti
distinct
describ
system
base
stabl
express
foreign
gene
integr
nuclear
chloroplast
genom
transient
express
target
protein
synthes
plant
cell
rel
short
time
sever
day
without
insert
plant
genom
present
fol
low
approach
use
transient
gene
expr
sion
plant
gene
deliveri
help
agrobac
terium
use
plant
viru
vector
magnifec
tion
tobacco
mosaic
viru
tmv
potato
x
viru
alfalfa
mosaic
viru
cowpea
mosaic
viru
use
viru
vector
avail
infec
tiou
cdna
clone
small
size
viral
genom
short
time
requir
express
target
gene
high
level
express
provid
high
attract
system
rapid
develop
express
system
led
substanti
modif
first
gene
inser
tion
vector
full
viru
vector
recombi
nant
viru
behav
wild
type
viru
capabl
express
addit
gene
next
step
creation
disarm
vector
deconstruct
vec
tor
lack
number
origin
viru
gene
gene
replac
vector
portion
viral
gene
replac
alien
gene
viral
vector
sever
substanti
disadvantag
tendenc
loss
foreign
insert
process
viru
spread
plant
potenti
risk
envi
ronment
relat
presenc
infecti
recombi
nant
viral
particl
launch
vector
repres
altern
recom
binant
plant
virus
cdna
virus
deliv
ere
plant
within
dna
region
agrobacteri
ti
plasmid
firstli
primari
transcript
dna
occur
nucleu
viral
rna
releas
cytoplasm
amplif
tran
lation
protein
synthesi
occur
system
agroinfiltr
base
use
plant
virus
agrobacteri
binari
plasmid
upgrad
name
magnifect
magnifect
multipl
agrobacteri
line
carri
differ
part
tmv
genom
use
simulta
neousli
agrobacteri
transfer
plant
cell
nucleu
separ
part
viral
genom
assembl
plant
complet
function
viral
replicon
substanti
modif
viral
genom
includ
numer
point
mutat
remov
potenti
site
splice
intron
insert
remov
gene
encod
envelop
protein
pro
vide
highli
effici
system
capabl
recom
binant
protein
synthesi
gkg
fresh
tissu
tsp
among
disadvantag
transient
system
necess
recombin
protein
isol
purifi
cation
immedi
accumul
plant
distinct
seed
fruit
plant
leav
stem
store
long
time
system
transient
express
recombin
protein
rather
promis
case
rapid
product
small
amount
protein
requir
experi
transient
express
plant
held
indoor
reduc
risk
associ
biosafeti
almost
zero
exampl
manufactur
immunogen
protein
veterinari
use
transient
express
system
present
tabl
sy
tem
transient
express
product
recombin
protein
describ
detail
review
candid
plant
vaccin
veterinari
use
tabl
present
exampl
use
variou
expr
sion
system
product
candid
plant
vaccin
veterinari
use
main
specif
immunogen
protein
synthes
respect
diseas
structur
protein
hemagglutinin
glycoprotein
usual
use
antigen
commonli
use
method
transgen
construct
deliv
plant
cell
still
agrobacteri
transform
case
level
target
protein
express
rather
high
esp
cialli
system
transient
express
suitabl
product
commerci
experi
use
candid
plant
vac
cine
format
specif
immun
respons
demonstr
vivo
experi
immunogen
protein
deliv
anim
oral
candid
plant
vaccin
usual
test
mice
approxim
quarter
work
ani
mal
subject
diseas
test
protein
transmiss
swine
gastroenter
viru
synth
size
cell
transgen
maiz
tobacco
deliv
bodi
pig
food
supplement
provid
surviv
ani
mal
infect
rabbit
protein
viru
synthes
potato
plant
tobacco
pea
rape
deliv
oral
enhanc
protect
immun
infect
rabbit
viru
ani
mal
surviv
effect
plant
recombin
antigen
compar
commerci
use
vac
cine
use
plant
vaccin
vaccin
wild
anim
use
edibl
bait
eg
vaccin
rabi
lead
increas
proport
wild
anim
popul
immun
rabi
viru
potenti
possibl
reduc
cost
produc
tion
biopharmaceut
use
genet
modifi
plant
serv
end
xx
centuri
imp
tu
twenti
biotechnolog
compani
initi
commerci
program
seen
tabl
mani
biolog
product
plant
origin
develop
express
differ
type
plant
plant
cell
cultur
varieti
reason
includ
still
skeptic
attitud
human
commun
biosafeti
genet
modifi
plant
mani
work
remain
framework
laboratori
test
moment
three
compani
function
biotechnolog
market
veterinari
prepar
two
unit
state
one
canada
tabl
unit
state
dow
agro
scienc
compani
present
recombin
plant
viral
hn
protein
newcastl
diseas
viru
approv
usda
mixtur
antivir
vaccin
first
stage
clinic
trial
second
american
compani
thoma
jef
ferson
univers
develop
plant
anti
rabi
vaccin
complet
phase
canadian
guardian
bioscienc
compani
present
plant
vac
cine
chicken
coccidiosi
second
phase
clinic
trial
product
wide
distribut
biopharmaceu
tical
hamper
number
circumst
first
relat
problem
biosafetyth
cultiv
genet
modifi
plant
field
lead
accident
introduct
foreign
gene
crop
grown
human
consumpt
therefor
compani
produc
biopharma
ceutic
focus
plant
speci
absent
food
chain
human
anim
also
grow
genet
modifi
plant
prevent
cross
pollin
crop
second
difficulti
relat
necess
plant
materi
treatment
remov
variou
undesir
com
pound
lignin
proteas
phenol
com
pound
pigment
especi
case
plant
speci
consum
fact
result
requir
addit
studi
third
cir
cumstanc
due
fact
aspect
maintain
grow
plant
produc
biop
harmaceut
settl
legisl
level
ambigu
vagu
exist
legisl
area
lead
fact
larg
biopharmaceut
biotechnolog
compani
tend
invest
develop
technolog
line
research
program
area
significantli
inhibit
develop
industri
signific
problem
develop
vac
cine
veterinari
use
especi
use
agri
cultur
need
minim
price
final
product
vaccin
inexpens
entr
preneur
engag
commerci
anim
breed
fulli
subsid
intend
use
vaccin
mass
immun
prevent
diseas
spread
underdevelop
region
result
potenti
incom
manufactur
vaccin
ani
mal
much
less
vaccin
intend
human
exampl
volum
mar
ket
vaccin
human
papilloma
viru
estim
billion
dollar
mar
ket
popular
anim
vaccin
foot
mouth
diseas
cattl
mycoplasma
hyopneumonia
pig
togeth
amount
amount
anim
vaccin
cheaper
volum
market
less
therefor
invest
develop
substanti
less
compar
invest
product
vaccin
human
wherea
com
plexiti
divers
host
pathogen
case
vaccin
anim
much
higher
express
system
base
use
plant
cell
still
limit
applic
use
primarili
laboratori
nevertheless
biopharm
biotechnolog
product
variou
substanc
medicin
plant
attract
attent
research
manufactur
develop
countri
first
biopharmaceut
plant
origin
anti
bodi
anti
hbsag
requir
purifi
hepat
b
vaccin
therapeut
dietari
protein
intrins
factor
requir
vitamin
defici
gastric
lipas
enter
market
excel
illustr
progress
despit
fact
today
number
biophar
maceut
protein
express
plant
cell
enor
mou
mani
question
still
remain
unresolv
method
target
recombin
protein
quantif
purif
still
develop
product
problem
transgen
silenc
increas
express
target
protein
gene
still
stage
research
import
task
yet
solv
achiev
stabl
level
express
differ
batch
plant
raw
materi
much
work
appear
judg
maintain
sta
biliti
recombin
protein
harvest
pro
cess
storag
problem
requir
addit
expens
research
one
main
obstacl
lead
research
group
work
develop
product
plant
vaccin
given
financi
constraint
fulfil
relev
offici
regul
govern
ing
use
oral
medic
date
purifi
vaccin
therapeut
protein
plant
origin
must
meet
standard
relat
product
biosafeti
purif
storag
dosag
etc
recombin
protein
medic
purpos
nevertheless
despit
difficulti
first
biopharmaceut
plant
origin
pass
necessari
test
approv
use
relev
author
new
product
spe
cific
advantag
similar
product
obtain
mammalian
cell
cultur
develop
com
pani
sembiosi
genet
inc
calgari
ada
medicago
inc
quebec
canada
protalix
bio
therapeut
karmiel
israel
orf
genet
iceland
prove
possibl
quick
establish
product
purifi
plant
protein
quit
competit
today
market
progress
made
format
legal
framework
relat
cultiv
transgen
plant
test
use
plant
biopharmaceut
sever
product
pro
cess
base
transgen
plant
alreadi
receiv
brand
gmp
good
manufactur
practic
interest
manufactur
field
biotechnolog
began
increas
work
perform
within
framework
project
develop
improv
genet
construct
optim
express
target
gene
product
recombi
nant
protein
medic
purpos
transgen
plant
anim
